Phathom Pharmaceuticals (PHAT) Asset Utilization Ratio (2022 - 2025)
Historic Asset Utilization Ratio for Phathom Pharmaceuticals (PHAT) over the last 4 years, with Q3 2025 value amounting to 0.6.
- Phathom Pharmaceuticals' Asset Utilization Ratio rose 70692.7% to 0.6 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.6, marking a year-over-year increase of 70692.7%. This contributed to the annual value of 0.14 for FY2024, which is 581790.76% up from last year.
- According to the latest figures from Q3 2025, Phathom Pharmaceuticals' Asset Utilization Ratio is 0.6, which was up 70692.7% from 0.42 recorded in Q2 2025.
- In the past 5 years, Phathom Pharmaceuticals' Asset Utilization Ratio ranged from a high of 0.6 in Q3 2025 and a low of 0.16 during Q1 2023
- Moreover, its 4-year median value for Asset Utilization Ratio was 0.02 (2024), whereas its average is 0.09.
- Per our database at Business Quant, Phathom Pharmaceuticals' Asset Utilization Ratio skyrocketed by 10140.74% in 2023 and then soared by 678917.1% in 2024.
- Phathom Pharmaceuticals' Asset Utilization Ratio (Quarter) stood at 0.15 in 2022, then skyrocketed by 101.41% to 0.0 in 2023, then skyrocketed by 6789.17% to 0.14 in 2024, then skyrocketed by 315.67% to 0.6 in 2025.
- Its last three reported values are 0.6 in Q3 2025, 0.42 for Q2 2025, and 0.24 during Q1 2025.